International Glaucoma Review

The Journal for the World Glaucoma Association

Strengthening the Link Between IOP Efficacy and Progression

Considering how progression trials could be shortened: what is the role of different analytical methods?

B. Chauhan

Detection of glaucomatous visual field progression often takes a considerable length of time, requiring frequent and regular testing over several years. More precise analytical tools would be needed to shorten the duration of clinical trials evaluating treatment effect on disease progression. Robust and meaningful estimates of variability and test-retest variability are required, and clarity is needed on what constitutes meaningful change. Either event-based or trend-based approaches to change analysis can be adopted to derive information on degree or rate of change. Compared with the event-based approach, trend based approaches are more appropriate for providing information on the rate of progression, which is important for clinical decisions. Trend-based analysis represents a linear regression analysis of data over time, with a comparison made with the patient’s own data. This approach has certain advantages, particularly when many examinations are available as the visual field measurements over time can be used to determine the rate and magnitude of change over time. The tools that have been developed for longitudinal analysis include the Glaucoma Progression Analysis (GPA), the Topographical Change Analysis (TCA) on the HRT and linear regression techniques. Event analysis may identify progressive test locations with as few as three test results, but it is dependent on the degree of change exceeding test-retest variability, which can be high for damaged locations. In perimetry, population-based estimates are used as surrogates for individual-specific estimates of variability. To maintain reasonable specificity, most investigators have found it necessary to have glaucoma change probability points outside normal limits to be confirmed on two or more tests. While longitudinal analysis is a more appropriate approach than cross-sectional analysis, it has rarely been used in recent glaucoma trials.

There are many quantitative assessments that can be done when seeking to measure or monitor structural change. Growing experience with modern imaging techniques will help identify which parameters best represent clinically meaningful information in the measurement of change. The detection of change will aid the clinician not only in assessment of progression of existing damage but also establishing the diagnosis of glaucoma. How much change is meaningful in glaucomaand how do we select criteria for change? Change criteria must reflect what relevant false positive rate can be tolerated. Methods for estimating false-positive rates include using the rate of change in a group of healthy patients, the rate of improvement in the same eye or use of permutation analysis for determining rate of change in the optic disc or visual field.

Because modern imaging devices allow measurements of the optic disc surface, depth and shape parameters such as cup volume, maximum cup death, and cup shape measure can also be determined. Localized analysis of the height measurements of the optic disc surface and peripapillary retina can be conducted using a probability-based analysis called topographic change analysis (Chauhan et al., 2000). With this technique, clusters of pixels where change has occurred can be analyzed over time using a variety of methods. Statistic image mapping, a proven quantitative technique widely used in neuroimaging, has been shown to have better diagnostic precision in detecting change in series of HRT images when compared with current quantitative techniques (Patterson et al., 2005). A pixel-by-pixel analysis of topographic height over time yields a statistic image that is generated by using permutation testing, derives significance limits for change wholly from the patient’s own data, and removes the need for reference data sets. These are examples of potential new statistical techniques for quantitative assessment of structural progression that could ultimately help shorten trial duration. It should be borne in mind that current clinical indicators of visual function and measures of optic disc structure provide largely independent measures of progression in OAG (Artes and Chauhan, 2005).

Contact | Copyright | Privacy | Terms of use
Search
View MyIGR bookmarks
Download pdf's
Printer friendly version of this page
Help